Glenmede Trust’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,160
Closed -$32K 2370
2020
Q3
$32K Buy
4,160
+872
+27% +$7.13K ﹤0.01% 1449
2020
Q2
$21K Buy
3,288
+2,097
+176% +$13.6K ﹤0.01% 1584
2020
Q1
$11K Hold
1,191
﹤0.01% 2404
2019
Q4
$11K Buy
1,191
+884
+288% +$9.31K ﹤0.01% 2404
2019
Q3
$3 Sell
307
-519
-63% -$5.33K ﹤0.01% 2801
2019
Q2
$9 Sell
826
-2,265
-73% -$23K ﹤0.01% 2433
2019
Q1
$28 Buy
3,091
+2,191
+243% +$24.2K ﹤0.01% 1950
2018
Q4
$8 Buy
+900
New +$10K ﹤0.01% 2385
2018
Q2
Sell
-582
Closed -$8K 2379
2018
Q1
$8K Hold
582
﹤0.01% 2267
2017
Q4
$8K Sell
582
-313
-35% -$4.35K ﹤0.01% 2267
2017
Q3
$12K Buy
895
+400
+81% +$5.17K ﹤0.01% 2134
2017
Q2
$6K Hold
495
﹤0.01% 2256
2017
Q1
$6K Buy
+495
New +$5.87K ﹤0.01% 2256
2013
Q3
Sell
-200
Closed -$2K 2273
2013
Q2
$2K Buy
+200
New +$2.68K ﹤0.01% 2100

Other funds holding MDRX

Glenmede Trust's MDRX Position: Q4 2020 in Review

Glenmede Trust sold out of Veradigm Inc. Common Stock (MDRX) in Q4 2020, closing a stake of 4,160 shares — an estimated $32K sold.

Glenmede Trust first reported a position in MDRX in Q2 2013 and held it in 14 quarters. The position peaked at $32K in Q3 2020. 217 funds tracked by Wall St. Rank hold MDRX as of Q4 2020.

  • Glenmede Trust reported no remaining Veradigm Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 4,160 Veradigm Inc. Common Stock shares in Q4 2020, an estimated $32K.
  • Glenmede Trust first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 14 quarters.
  • Glenmede Trust's Veradigm Inc. Common Stock position peaked at $32K in Q3 2020.
  • 217 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.